Skip to main content
. 2021 Feb 18;78(9):4235–4257. doi: 10.1007/s00018-021-03783-0

Table 9.

Role of POT1 in different cancer types

Human malignancy POT1 expression levels Suggested functional outcome Ref
Breast cancer Downregulation of POT1 mRNA Dysregulation of telomerase activity [264]
Colorectal cancer Upregulation of POT1 mRNA and protein [170, 265]
Gastric cancer Downregulation of POT1 mRNA in early cancer stage Telomere dysfunction in early-stage cancer [266]
Downregulation of POT1; expression decreases with disease severity [256]
Glioblastoma Downregulation of POT1 Poorer prognosis [267]
Hepatocellular carcinomas (HBV-related) Upregulation of POT1 mRNA Preserved 3′ overhang length, unlimited division of cancer cells, increased chromosomal instability [175]
Downregulation of POT1 mRNA and protein Poorer prognosis [180182]
Splenic marginal zone lymphomas Downregulation of POT1 Increased chromosomal instability [268]
Melanoma Upregulation of POT1 [269]
Familial papillary thyroid cancer Downregulation of POT1 as compared to sporadic cancers [240]